Generate Biomedicines
Clinical trials sponsored by Generate Biomedicines, explained in plain language.
-
New eczema drug candidate enters first human safety tests
Disease control OngoingThis early-stage trial tests the safety of a new drug called GB-7624 in 40 healthy adults. It is the first time this drug is being given to humans. The study gives single or multiple doses under the skin to see if it is safe and how the body processes it. If successful, it may ev…
Phase: PHASE1 • Sponsor: Generate Biomedicines • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
New biologic GB-0895 enters first human safety trial for asthma and COPD
Disease control OngoingThis early-stage study is testing an experimental drug called GB-0895 in 156 adults with mild-to-moderate asthma or COPD. The main goal is to check if the drug is safe and how the body processes it. Participants receive either the drug or a placebo as an injection under the skin.…
Phase: PHASE1 • Sponsor: Generate Biomedicines • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC